News Maxigen Biotech Inc.

Equities

1783

TW0001783009

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
42.9 ^TWD	-0.23%		+1.54%	-11.36%

Mar. 21	Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Maxigen Biotech Inc.(TWSE:1783) added to S&P Global BMI Index	23-09-18	CI
Maxigen Biotech Inc. Declares Dividend, Payable on October 12, 2023	23-08-23	CI
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-26	CI
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2022 to December 31, 2022	23-05-03	CI
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Maxigen Biotech Inc. Announces Executive Changes	23-03-22	CI
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended December 2022	23-01-06	CI
Maxigen Biotech Inc. Announces Resignation of You Wan-How as Financial Officer and Accounting Officer	22-12-29	CI
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended November 2022	22-12-06	CI
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended October 2022	22-11-07	CI
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-25	CI
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-To-Date Ended September 2022	22-10-05	CI
Maxigen Biotech : Monthly revenue report, July 2022	22-08-09	PU
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-to-Date Ended July 2022	22-08-09	CI
Maxigen Biotech : Board of Directors' Resolution for the change of the chief internal auditor	22-08-03	PU
Maxigen Biotech : Board of Directors approved the financial reports for the second quarter of 2022	22-08-03	PU
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Maxigen Biotech Inc.

Equities

1783

TW0001783009

Summary

Filters